35 "

: Fabrazyme 35 Mg. ?  »
|
-

I.V

Powder For Concentrate For Infusion

Fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease. (alfa - galactosidase A deficiency).

124 94 30313 00

Genzyme Corporation, Usa

06/2012 - 05/2017

.
, .
.
/
Agalsidase beta 35 MG/VIAL
Vial glass type i 1 x 20 ML 36
Vial glass type i 5 x 20 ML 36
Vial glass type i 10 x 20 ML 36

*

*

 

.

 
" !
 
278
,